An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Repare Therapeutics Inc. (Nasdaq: RPTX) announced its participation in two investor conferences: the Guggenheim Oncology Conference on February 9, 2023, at 3:20 p.m. ET in New York, and the Cowen 43rd Annual Health Care Conference on March 8, 2023, at 9:50 a.m. ET in Boston. Investors can access live webcasts of the events via the Company’s website, with replays available for 30 days. Repare is focused on precision oncology, using its proprietary SNIPRx® platform for developing targeted cancer therapies, including ongoing Phase 1 trials of RP-6306 and camonsertib (RP-3500), and additional preclinical programs.
Positive
None.
Negative
None.
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate at two investor conferences in February and March. Details for the fireside chats are as follows:
Guggenheim Oncology Conference Date: Thursday, February 9, 2023 Time: 3:20 p.m. Eastern Time Location: New York, NY
Cowen 43rd Annual Health Care Conference Date: Wednesday, March 8, 2023 Time: 9:50 a.m. Eastern Time Location: Boston, MA
A live webcast of the fireside chats can be accessed in the Investor section of the Company’s website at https://ir.reparerx.com/news-and-events/events. A replay of the webcasts will be archived on the Company’s website for at least 30 days.
About Repare Therapeutics, Inc.
Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes RP-6306, a PKMYT1 inhibitor currently in Phase 1 clinical development; camonsertib (also known as RP-3500), a potential leading ATR inhibitor currently in Phase 1/2 clinical development partnered with Roche; RP-2119, a Polθ inhibitor program in ongoing IND-enabling studies; as well as several additional, undisclosed preclinical programs. For more information, please visit reparerx.com.
SNIPRx® is a registered trademark of Repare Therapeutics Inc.
What are the dates of the upcoming investor conferences for RPTX?
Repare Therapeutics will participate in the Guggenheim Oncology Conference on February 9, 2023, and the Cowen 43rd Annual Health Care Conference on March 8, 2023.
Where can I watch the live webcasts for RPTX's investor conferences?
The live webcasts for RPTX's investor conferences can be accessed on the Investor section of Repare's website.
What is the focus of Repare Therapeutics Inc. (RPTX)?
Repare Therapeutics focuses on precision oncology using its SNIPRx® platform to discover and develop targeted cancer therapies.
What therapies are currently in development by RPTX?
Repare has several therapies in development, including RP-6306, a PKMYT1 inhibitor, and camonsertib (RP-3500), an ATR inhibitor in Phase 1/2 clinical development.
How can I find more information about Repare Therapeutics (RPTX)?
More information about Repare Therapeutics can be found on their official website at reparerx.com.
